Introduction to: Neurotoxin-based Nonhuman Primate Models of Parkinson's Disease

Parkinson's Disease

Volumn , Issue , 2008, Pages 49-54

  Zhang, Zhiming ^a   Gash, Don Marshall ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84882507244     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-374028-1.00004-X     Document Type: Chapter

References (25)

1. Albanese A., Granata R., Gregori B., et al. Chronic administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine to monkeys: behavioural, morphological and biochemical correlates. Neuroscience 1993, 55:823-832.
2. Andersen A.H., Zhang Z., Zhang M., et al. Age-associated changes in rhesus CNS composition identified by MRI. Brain Res. 1999, 829:90-98.
3. Bohnen N.I., Albin R.L., Koeppe R.A., et al. Positron emission tomography of monoaminergic vesicular binding in aging and Parkinson disease. J Cereb Blood Flow Metab. 2006 Sep., 26(9):1198-1212.
4. Braak H., Ghebremedhin E., Rüb U., et al. Stages in the development of Parkinson's disease-related pathology. Cell Tissue Res. 2004, 318:121-134.
5. Crossman A.R., Clarke C.E., Boyce S., et al. MPTP-induced parkinsonism in the monkey: neurochemical pathology, complications of treatment and pathophysiological mechanisms. Can J Neurol Sci. 1987, 14:428-435.
6. Dawson T.M., Dawson V.L. Molecular pathways of neurodegeneration in Parkinson's disease. Science 2003, 302:819-822.
7. Ding F., Luan L., Ai Y., et al. Development of a stable, early stage unilateral model of Parkinson's disease in middle-aged rhesus monkeys. Exp Neurol. 2008, (in press).
8. Fearnley J.M., Lees A.J. Ageing and Parkinson's disease: substantia nigra regional selectivity. Brain 1991 Oct., 114(Pt 5):2283-2301.
9. Gash D.M., Rutland K., Hudson N.L., et al. Trichloroethylene: Parkinsonism and complex 1 mitochondrial neurotoxicity. Ann Neurol. 2008 Feb., 63(2):184-192.
10. Hawkes C.H., Del Tredici K., Braak H. Parkinson's disease: a dual-hit hypothesis. Neuropathol Appl Neurobiol. 2007, 33:599-614.
11. Lang, A. E., and Lozano, A. M. Parkinson's disease. First of two parts. N Engl J Med.
12. Langston J.W., Ballard P., Tetrud J.W., Irwin I. Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis. Science 1983, 219:979-980.
13. Lee C.S., Schulzer M., de la Fuente-Fernández R., et al. Lack of regional selectivity during the progression of Parkinson disease: implications for pathogenesis. Arch Neurol. 2004 Dec., 61(12):1920-1925.
14. Moratalla R., Quinn B., DeLanney L.E., et al. Differential vulnerability of primate caudate-putamen and striosome-matrix dopamine systems to the neurotoxic effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Proc Natl Acad Sci U S A 1992, 89:3859-3863.
15. Mounayar S., Boulet S., Tande D., et al. A new model to study compensatory mechanisms in MPTP-treated monkeys exhibiting recovery. Brain 2007, 130:2898-2914.
16. Nicklas W.J., Youngster S.K., Kindt M.V., Heikkila R.E. MPTP, MPP+ and mitochondrial function. Life Sci. 1987, 40:721-729.
17. Ovadia A., Zhang Z., Gash D.M. Increased susceptibility to MPTP toxicity in middle-aged rhesus monkeys. Neurobiol Aging 1995, 16:931-937.
18. Richardson J.R., Caudle W.M., Guillot T.S., et al. Obligatory role for complex I inhibition in the dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). Toxicol Sci. 2007, 95:196-204.
19. Ross C.A., Pickart C.M. The ubiquitin-proteasome pathway in Parkinson's disease and other neurodegenerative diseases. Trends Cell Biol. 2004, 14:703-711.
20. Schneider J.S., Yuwiler A., Markham C.H. Selective loss of subpopulations of ventral mesencephalic dopaminergic neurons in the monkey following exposure to MPTP. Brain Res. 1987, 411:144-150.
21. Silver D. Impact of functional age on the use of dopamine agonists in patients with Parkinson disease. Neurologist 2006, 12:214-223.
22. Tetrud J.W., Langston J.W., Garbe P.L., Ruttenber A.J. Mild parkinsonism in persons exposed to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). Neurology 1989, 39:1483-1487.
23. Totterdell S., Meredith G.E. Localization of alpha-synuclein to identified fibers and synapses in the normal mouse brain. Neuroscience 2005, 135:907-913.
24. Yavich L., Tanila H., Vepsäläinen S., Jäkälä P. Role of alpha-synuclein in presynaptic dopamine recruitment. J Neurosci 2004, 24:11165-11170.
25. Zhang Z., Andersen A.H., Smith C.D., et al. Motor slowing and parkinsonian signs in aging rhesus. J Gerontology: Biol Sci. 2000, 55A:B473-bB480.